SCI时时刷

search
+
Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry by Rosenbaum et al
Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry by Rosenbaum et al
We thank Rosenbaum et al 1 for their correspondence on our article.2 In their reply, they largely report updated results o...
Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing
Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing
IntroductionSystemic vasculitides comprise a heterogeneous group of immune-mediated disorders characterised by blood vesse...
Pathogenic antibody response to glucose-6-phosphate isomerase targets a modified epitope uniquely exposed on joint cartilage
Pathogenic antibody response to glucose-6-phosphate isomerase targets a modified epitope uniquely exposed on joint cartilage
AbstractObjectives To identify the arthritogenic B cell epitopes of glucose-6-phosphate isomerase (GPI) and their associat...
Response to: 'Correspondence on 'Onset of rheumatoid arthritis after COVID-19: coincidence or connected? by Roongta et al
Response to: 'Correspondence on 'Onset of rheumatoid arthritis after COVID-19: coincidence or connected? by Roongta et al
We thank Roongta et al 1 for the interest taken in our work and for bringing this interesting case of seropositive rheumat...
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Correspondence on 'SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease
Correspondence on 'SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease
We read with great interest the article published by D’Silva et al.1 The authors reported three patients with inadequate a...
Response to: 'Correspondence on 'SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease by C et al
Response to: 'Correspondence on 'SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease by C et al
We appreciate the comments by Shanoj et al 1 in response to our letter regarding the SARS-CoV-2 antibody response after CO...
Correspondence on 'Second COVID-19 infection in a patient with granulomatosis with polyangiitis on rituximab
Correspondence on 'Second COVID-19 infection in a patient with granulomatosis with polyangiitis on rituximab
We read with great interest the recent article by Fiedman and Winthrop reporting a patient with granulomatosis with polyan...
Response to: 'Correspondence on 'Second COVID-19 infection in a patient with granulomatosis with polyangiitis on rituximab by Tampe et al
Response to: 'Correspondence on 'Second COVID-19 infection in a patient with granulomatosis with polyangiitis on rituximab by Tampe et al
We read with great interest the report by Tampe et al regarding their patient with granulomatosis with polyangiitis on rit...
Correspondence on 'Onset of rheumatoid arthritis after COVID-19: coincidence or connected?
Correspondence on 'Onset of rheumatoid arthritis after COVID-19: coincidence or connected?
We read with great interest the letter by Derksen et al on ‘Onset of rheumatoid arthritis (RA) after COVID-19: coincidence...
Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study by Kaklamanos et al
Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study by Kaklamanos et al
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Response to: 'Correspondence on 'Risk of venous thromboembolism in rheumatoid arthritis and its association with disease activity: a nationwide cohort study from Sweden by Zervou et al
Response to: 'Correspondence on 'Risk of venous thromboembolism in rheumatoid arthritis and its association with disease activity: a nationwide cohort study from Sweden by Zervou et al
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Clinical and genetic factors associated with radiographic damage in patients with ankylosing spondylitis
Clinical and genetic factors associated with radiographic damage in patients with ankylosing spondylitis
WHAT IS ALREADY KNOWN ON THIS TOPICAnkylosing spondylitis (AS) is an inflammatory rheumatic disease characterised by progr...
Alterations in the cutaneous microbiome of patients with psoriasis and psoriatic arthritis reveal similarities between non-lesional and lesional skin
Alterations in the cutaneous microbiome of patients with psoriasis and psoriatic arthritis reveal similarities between non-lesional and lesional skin
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine
Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine
It is well recognised that hyperinflammation induced by SARS-CoV-2 is a major cause of disease severity and mortality in i...
Response to: 'Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine by Perricone et al
Response to: 'Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine by Perricone et al
We thank Drs Perricone et al for their thoughtful response1 to our manuscript, and agree that timing, dose and duration of...
Response to: 'Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis by Lee
Response to: 'Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis by Lee
We thank Lee1 for his comments to our research article ‘Prevalence and clinical outcomes of COVID-19 in patients with auto...
Vital corner of diagnostic challenge: eosinophilic granulomatosis with polyangiitis or COVID-19 pneumonia?
Vital corner of diagnostic challenge: eosinophilic granulomatosis with polyangiitis or COVID-19 pneumonia?
The COVID-19 pandemic raises many alarms in the rheumatological era. Gianfrancesco et al reported the answer of an importa...
Transient monoarthritis and psoriatic skin lesions following COVID-19
Transient monoarthritis and psoriatic skin lesions following COVID-19
Emerging reports have described the possible occurrence of arthritis in patients infected with severe acute respiratory sy...
Correspondence on 'Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden
Correspondence on 'Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden
We read with great interest an article by Molander et al 1 demonstrating a strong association between clinical rheumatoid ...
Mass spectrometry-based identification of new anti-Ly and known antisynthetase autoantibodies
Mass spectrometry-based identification of new anti-Ly and known antisynthetase autoantibodies
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Transplacental passage of belimumab during pregnancy and follow-up of a child exposed in utero
Transplacental passage of belimumab during pregnancy and follow-up of a child exposed in utero
A recent report from the Belimumab Pregnancy Registry (NCT01532310) analysed available data on the consequences of belimum...
Patients with a range of rheumatic diseases are at increased risk of cardiovascular disorders towards a re-evaluation of the European League against Rheumatism (EULAR)s recommendations for cardiovascular risk management?
Patients with a range of rheumatic diseases are at increased risk of cardiovascular disorders towards a re-evaluation of the European League against Rheumatism (EULAR)s recommendations for cardiovascular risk management?
The notion that patients with rheumatic disorders are at increased risk of developing cardiovascular diseases has been ong...
Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis
Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis
IntroductionGlucocorticoids (GC) are often part of the initial treatment of early rheumatoid arthritis (RA).1 2 Before slo...
Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells
Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Correspondence on 'Non-surgical and surgical treatments for rotator cuff disease: a pragmatic randomised clinical trial with 2-year follow-up after initial rehabilitation
Correspondence on 'Non-surgical and surgical treatments for rotator cuff disease: a pragmatic randomised clinical trial with 2-year follow-up after initial rehabilitation
With great interest, we read the relevant results of a randomised clinical trial designed to compare conservative and surg...
Response to: 'Correspondence on 'Non-surgical and surgical treatments for rotator cuff disease: a pragmatic randomised clinical trial with 2-year follow-up after initial rehabilitation by Randelli et al
Response to: 'Correspondence on 'Non-surgical and surgical treatments for rotator cuff disease: a pragmatic randomised clinical trial with 2-year follow-up after initial rehabilitation by Randelli et al
We warmly thank Randelli and coworkers for their interest in our work.1 Our randomised, pragmatic, controlled trial compar...
Response to: 'Correspondence on 'A pilot study of tofacitinib for refractory Behcets syndrome by Zou et al
Response to: 'Correspondence on 'A pilot study of tofacitinib for refractory Behcets syndrome by Zou et al
We thank Zou and colleagues for their interests and insightful comments1 on our recently published work2 and are impressed...
Correspondence on 'A pilot study of tofacitinib for refractory Behcets syndrome
Correspondence on 'A pilot study of tofacitinib for refractory Behcets syndrome
We carefully read the recent study by Liu et al on the effectiveness of tofacitinib for refractory Behçet’s syndrome (BS)....
Response to: 'Correspondence on 'Risk of venous thromboembolism in knee, hip and hand osteoarthritis: a general population-based cohort study by Lin et al
Response to: 'Correspondence on 'Risk of venous thromboembolism in knee, hip and hand osteoarthritis: a general population-based cohort study by Lin et al
Lin et al 1 raised three points with regard to residual confounding to affect our findings. Below we provide point-by-poin...
阅读更多
format_indent_increase